Universe Pharmaceuticals UPC
NASDAQ UPC
$4.51 -0.27 (-5.65%)
As of: Sep 30, 2026 · 9:30 AM EDT

Universe Pharmaceuticals (UPC) Receivables - Other (2021 - 2026)

Updated

Universe Pharmaceuticals (UPC) reported Receivables - Other of $7.18 trillion for the quarter ended Mar 31, 2026, up 114.0% from $3.36 trillion a year earlier.

Analysis

Universe Pharmaceuticals (UPC) Receivables - Other (2021 - 2026) Analysis & Trends

As of Sep 30, 2025, Universe Pharmaceuticals posted Receivables - Other of $2.28 trillion, down 59.8% from the prior year.

  • Receivables - Other has a four-year compound annual growth rate of 5469.8% (years ended Sep 2021 to Sep 2025).
  • By year, Receivables - Other came in at $5.67 trillion in the year ended Sep 30, 2024, $61.68 billion in the year ended Sep 30, 2023 and $236,982 in the year ended Sep 30, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Universe Pharmaceuticals 2.19 Mn -1,525.28 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 7,180.73 Bn
Sep 30, 2025 2.28 Mn
Mar 31, 2025 3,355.32 Bn
Sep 30, 2024 5.67 Bn
Sep 30, 2023 1.92 Mn
Mar 31, 2022 356,290.00
Sep 30, 2021 236,982.00
API Access

Universe Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=UPC&period=max&api_key=YOUR_API_KEY